Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Select Drug Profiles
Select Drug Profiles
Vizimpro (Dacomitinib) Approved for First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer with EGFR Mutation
Loretta Fala
Read More
Select Drug Profiles
Xospata (Gilteritinib) First Drug Approved as Monotherapy for Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation
Lisa A. Raedler, PhD, RPh
Read More
Select Drug Profiles
Yonsa (Fine-Particle Abiraterone Acetate) New Formulation Approved for Metastatic Prostate Cancer
Loretta Fala
Read More
Breast Cancer
,
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves First Hormonal-Based Therapy for Men with Advanced or Metastatic Breast Cancer
Read More
Breast Cancer
,
FDA Approvals
,
In the News
,
Select Drug Profiles
Proposed Landmark Policy Changes to Modernize Mammography and Raise Breast Density Awareness
Read More
FDA Approvals
,
In the News
,
Lung Cancer
,
Select Drug Profiles
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves Tecentriq plus Abraxane—First Immunotherapy for PD-L1– Positive Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
March 08, 2019 - FDA Approvals, News & Updates
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves Pembrolizumab for Treatment of Advanced Melanoma
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma
Read More
4
5
6
7
8
9
10
Page 7 of 13
Results 61 - 70 of 121